Kesimpta administration details: Forms, potencies, methods, and further insights
Kesimpta, a brand-name medication, is a prescription drug used to treat certain types of Multiple Sclerosis (MS). The active ingredient in Kesimpta is ofatumumab. It is available in two forms: a single-dose prefilled auto-injector pen (Sensoready pen) and a single-dose prefilled syringe.
During the initial treatment phase, Kesimpta is administered as weekly injections, with doses of 20 mg each at weeks 0, 1, 2, and skipping week 3. After the loading phase, Kesimpta is administered monthly.
Common side effects of Kesimpta include injection site reactions (such as pain or swelling where injected), headache, back pain, upper respiratory infections (like common cold), urinary tract infections (UTI), and whole-body injection reactions such as fatigue, muscle aches, chills, or fever.
It's important to note that while most side effects are mild and temporary, Kesimpta carries an increased risk of infections, including serious bacterial, fungal, and viral infections (such as COVID-19), and potentially reactivation of hepatitis B virus. Serious infections are relatively rare but possible and require medical attention. Additionally, rare serious side effects could involve allergic reactions and reduced immune system activity.
The recommended injection site for Kesimpta is the front of your thigh or your abdomen (belly), but not within 2 inches of your belly button. If a caregiver injects your dose, your outer upper arm is also an option.
If you miss a dose of Kesimpta, you should inject it as soon as possible, and the timing of your next dose depends on whether you're currently receiving the loading or maintenance dosage.
Kesimpta is meant to be a long-term treatment. If you have questions about how to use Kesimpta, ask your doctor or pharmacist. The manufacturer's website offers detailed instructions and a video on how to inject Kesimpta.
Kesimpta starts to work after your first dose, but it may take a few weeks before your symptoms ease. It belongs to a group of drugs called monoclonal antibodies.
In summary, while Kesimpta offers a potential treatment option for MS, it's crucial to be aware of its common and less common side effects, particularly the increased risk of infections. Always consult your healthcare provider if symptoms worsen or persist.
- Kesimpta, a drug used for certain types of multiple sclerosis, has multiple forms available, including a single-dose prefilled auto-injector pen and a single-dose prefilled syringe.
- During the initial treatment phase, deciders should administer Kesimpta as weekly injections, with doses of 20 mg each at weeks 0, 1, 2, and skipping week 3, followed by monthly doses.
- Common side effects of Kesimpta include injection site reactions, headache, back pain, upper respiratory infections, urinary tract infections, and whole-body injection reactions.
- It's important to note that Kesimpta carries an increased risk of infections, including bacterial, fungal, viral infections, and potential reactivation of hepatitis B virus.
- Proper nutrition and various therapies and treatments for managing multiple sclerosis and other neurological disorders can complement the use of Kesimpta in maintaining one's health and wellness.
- If a caregiver is injecting your dose, the outer upper arm can be used as an alternative injection site, in addition to the front of the thigh or abdomen.
